Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by FORSLIND, K.
Right arrow Articles by SAXNE, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FORSLIND, K.
Right arrow Articles by SAXNE, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 British Society for Rheumatology


other

INCREASED SERUM CONCENTRATIONS OF CARTILAGE OLIGOMERIC MATRIX PROTEIN. A PROGNOSTIC MARKER IN EARLY RHEUMATOID ARTHRITIS

K. FORSLIND*,, K. EBERHARDT*, A. JONSSON{dagger} and T. SAXNE*,{ddagger}

*Department of Rheumatology, Lund University Hospital Lund, Sweden
*Department of Radiology, Lund University Hospital Lund, Sweden
{ddagger}Department of Physiological Chemistry, Lund University Lund, Sweden

Correspondence to: Correspondence to K. Forslind, Department of Rheumatology, Lund University Hospital, S-221 85 Lund, Sweden

Two cartilage specific macromolecules, cartilage oligomeric matrix protein (COMP) and proteoglycan, were quantified by immunoassay in sera of two groups of patients with rheumatoid arthritis (RA) of recent onset to evaluate the prognostic value of such measurements. Patients with rapidly progressive joint destruction had increased COMP concentrations initially, which subsequently decreased. A group with more benign disease, and less extensive joint damage, had normal COMP levels throughout the study period. Serum concentrations of proteoglycan were normal in both groups. Thus measurement of COMP in serum early in the course of RA holds promise as a prognostic marker for development of joint destruction in this disease

KEY WORDS: Non-collagenous cartilage matrix protein, Proteoglycan, Prognosis, Joint destruction


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
Z. de Jong, M. Munneke, V. Vilim, A. H. Zwinderman, H. M. Kroon, H. K. Ronday, W. F. Lems, B. A. C. Dijkmans, F. C. Breedveld, T. P. M. Vliet Vlieland, et al.
Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study
Rheumatology, June 1, 2008; 47(6): 868 - 871.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
H Forsblad d'Elia, A Larsen, E Waltbrand, G Kvist, D Mellstrom, T Saxne, C Ohlsson, E Nordborg, and H Carlsten
Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis
Ann Rheum Dis, July 1, 2003; 62(7): 617 - 623.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A A den Broeder, L A B Joosten, T Saxne, D Heinegard, H Fenner, A M M Miltenburg, W L H Frasa, L J van Tits, W A Buurman, P L C M van Riel, et al.
Long term anti-tumour necrosis factor {alpha} monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation
Ann Rheum Dis, April 1, 2002; 61(4): 311 - 318.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
P. Roux-Lombard, K. Eberhardt, T. Saxne, J.-M. Dayer, and F. A. Wollheim
Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study
Rheumatology, May 1, 2001; 40(5): 544 - 551.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
T. Conrozier, T. Saxne, C. S. S. Fan, P. Mathieu, A.-M. Tron, D. Heinegård, and E. Vignon
Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study
Ann Rheum Dis, September 1, 1998; 57(9): 527 - 532.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Thur, K. Rosenberg, D. P. Nitsche, T. Pihlajamaa, L. Ala-Kokko, D. Heinegard, M. Paulsson, and P. Maurer
Mutations in Cartilage Oligomeric Matrix Protein Causing Pseudoachondroplasia and Multiple Epiphyseal Dysplasia Affect Binding of Calcium and Collagen I, II, and IX
J. Biol. Chem., February 23, 2001; 276(9): 6083 - 6092.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.